Full profile

Also known asPrevagen
Best forHistorically marketed for memory support — not applicable to a healthy-adult focus product
Evidence gradeGraded Out — Graded out — evaluated and not featured (failed replication or a safety signal)
Studied dose rangeNot applicable — not a candidate for inclusion.
Time to effectNot applicable.
Best formNot applicable.

Evidence, honestly graded

Graded out on both efficacy and plausibility grounds. Apoaequorin's own sponsor-run Madison Memory Study failed its pre-specified primary endpoints. The FTC and multiple state attorneys general pursued deceptive-advertising actions against Prevagen's marketing claims. Mechanistically, apoaequorin is an orally ingested protein: it is digested in the gastrointestinal tract like any other dietary protein and has no established route to reach or act on the brain intact. Do not feature.

See the full grading rubric — study type, replication, population match, and dose adequacy — in The Evidence Standard.

Side effects

  • Generally reported as well tolerated in marketing materials — not the basis for exclusion

What to look for on a label

  • Documented here for transparency only — not a candidate ingredient under any circumstance.

References

  • Madison Memory Study — apoaequorin sponsor-run trial. Sponsor-run trial failed its pre-specified primary endpoints for memory and cognitive function. Basis for the Graded Out status. Educational.
  • FTC action re: Prevagen (apoaequorin) marketing claims. The FTC and multiple state attorneys general pursued deceptive-advertising actions over Prevagen's memory claims. Educational, historical/regulatory background.

Primary citations for some entries above are still being compiled; those without a linked identifier are editorial summaries of the wider literature.

Grades and studied doses are our conservative reading of the human research, shown for education. They are not product claims, and a studied dose is not a recommended dose.

See how Apoaequorin compares on grade, dose, and goal in the Evidence Explorer.